Support of M&A delas, investment and project financing transactions

We advise companies, owners and financial institutions in risk assessment, marketing analysis, commercial operations - those which are planning to attract financing, invest or divest.

We support investment and divestment deals of:

  1. Patented and generic pharmaceutical manufacturers.
  2. Medical equipment manufacturers.
  3. Manufacturers of food supplements, medical devices and parapharmaceutical products.
  4. Healthcare sector companies: laboratories, clinics

We cover the following region:

  1. Central and Eastern Europe countries.
  2. CIS region countries.
  3. Central Asia countries.

We focus on:

  1. Screening and identification of potential targets for investment/divestments or acquisition - preparing "long-list" and "short-list".
  2. Preparation of transaction documentation: non-disclosure agreement, letter of intent, investment teaser, investment memorandum, etc.
  3. Deal process management.
  4. Assessment of investment potential and risks.
  5. Strategic analysis of the consequences of investing / acquisitions on further development.

Commercial & Marketing Audit of Pharma and Healthcare companies

Project examples.

Our clients:

  1. Pharmaceutical manufacturers: generic and patented products.
  2. Medical equipment manufacturers.
  3. Investment banks and Private equity funds.
  4. Healthcare companies.

Operational audit. Audit and assessment of the management team, manufacturing process audit. Audit of a distribution system and analysis of suppliers and customers. Audit of commercial and operating activities. Audit of the regulatory environment in domestic and foreign markets.

Marketing audit. Audit of market potential opportunities: current position in the market and possible prospects. Analysis of the company's key markets: its competitors, demand potential, consumption structure and main stakeholders in the distribution chain.

Export and import audit. Analysis of export-import opportunities, assessment of growth potential, prospects of entering new markets. Audit of the procurement of raw materials, production equipment.



Consulting in the field of M&A deals, Pre-investment due diligence, Commercial audit, Business diagnostics and Market Access. Please contact Mr Eugene Brovko tel.: +380 (98) 224-98-64 or via e-mail: for additional information.

Wrong E-mail
Input your name
Input subject
Input your message
Message sent.
Problems in the form fields, please, recheck!
Проблемы со связью!

Feedback form

Leave your message

UPharma Consulting, Ltd.

Let's stay in touch

"UPharma Consulting"
Holosiivskiy avenue, 30B
office 58
Kyiv, 03039

Telephone: + 380 (97) 953 68 14